Combined antenatal thyrotropin-releasing hormone and low-dose glucocorticoid therapy improves the pulmonary biochemical immaturity in congenital diaphragmatic hernia

https://doi.org/10.1016/0022-3468(94)90348-4Get rights and content

Abstract

The lungs of patients born with severe congenital diaphragmatic hernia (CDH) are biochemically and morphologically immature. Because antenatal glucocorticoid therapy can accelerate pulmonary maturation in premature neonates who have respiratory distress syndrome, we hypothesized that it may correct the pulmonary biochemical and morphological immaturity associated with CDH. We showed in previous experimental studies that antenatal low-dose dexamethasone improved the biochemical and morphological parameters of pulmonary immaturity in rats that had severe CDH. Somatic and pulmonary growth were inhibited with high doses of dexamethasone. In the present study, we examined the effects of antenatal low-dose dexamethasone and thyrotropin-releasing hormone (TRH), alone or in combination, on the pulmonary maturation in CDH. Combined antenatal low-dose dexamethasone and TRH significantly reduced mean lung glycogen concentration (P = .001), and increased mean disaturated phosphatidylcholine content (P < .005) to better than that observed with either therapy alone, without changing mean body or lung weight. Combined TRH and low-dose glucocorticoid as an antenatal therapy may reduce the morbidity and mortality of CDH.

References (46)

  • JWC Johnson et al.

    Betamethasone and the rhesus fetus: Multisystemic effects

    Am J Obstet Gynecol

    (1979)
  • U Devaskar et al.

    Transplacental stimulation of functional and morphologic fetal rabbit lung maturation: Effect of thyrotropin-releasing hormone

    Am J Obstet Gynecol

    (1987)
  • M Oulton et al.

    Gestation-dependent effects of the combined treatment of glucocorticoids and thyrotropin-releasing hormone on the surfactant production by fetal rabbit lung

    Am J Obstet Gynecol

    (1989)
  • AP Bos et al.

    Surfactant replacement therapy in high-risk congenital diaphragmatic hernia

    Lancet

    (1991)
  • PL Glick et al.

    Pathophysiology of congenital diaphragmatic hernia III: Exogenous surfactant therapy for the high-risk neonate with CDH

    J Pediatr Surg

    (1992)
  • W Areechon et al.

    Hypoplasia of lung with congenital diaphragmatic hernia

    Brit Med J

    (1963)
  • M Kitagawa et al.

    Lung hypoplasia in congenital diaphragmatic hernia

    Br J Surg

    (1971)
  • L Nguyen et al.

    The mortality of congenital diaphragmatic hernia. Is total pulmonary mass inadequate, no matter what?

    Ann Surg

    (1983)
  • P Puri et al.

    Natural history of congenital diaphragmatic hernia: Implications for management

    Pediatr Surg Int

    (1987)
  • WR Blackburn et al.

    Congenital diaphragmatic hernia: Studies of lung composition and structure

    Am Rev Respir Dis

    (1977)
  • JS Wigglesworth et al.

    Fetal lung hypoplasia: Biochemical and structural variations and their possible significance

    Arch Dis Child

    (1981)
  • C Berk et al.

    High risk' lecithin/sphingomyelin ratios associated with neonatal diaphragmatic hernia. Case reports

    Br J Obstet Gynecol

    (1982)
  • DK George et al.

    Hypoplasia and immaturity of the terminal lung unit (acinus) in congenital diaphragmatic hernia

    Am Rev Respir Dis

    (1987)
  • Cited by (0)

    Presented at the 24th Annual Meeting of the American Pediatric Surgical Association, Hilton Head, South Carolina, May 15–18, 1993.

    View full text